1. Decrease in autoantibody titres during long-term treatment of scleroderma with rituximab: a promising surveillance marker of therapy?. (2nd November 2015) Authors: Moazedi-Fuerst, FC; Kielhauser, SM; Hermann, J; Meilinger, M; Demel, U; Stradner, MH; Graninger, WB Journal: Scandinavian journal of rheumatology Issue: Volume 44:Number 6(2015) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen. (May 2014) Authors: Moazedi-Fuerst, FC; Kielhauser, SM; Brickmann, K; Hermann, J; Lutfi, A; Meilinger, M; Brezinschek, HP; Graninger, WB Journal: Scandinavian journal of rheumatology Issue: Volume 43:Number 3(2014) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗